Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion type Assertion NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_head.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion wasGeneratedBy ECO_0000203 NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_provenance.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion wasDerivedFrom befree-2016 NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_provenance.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion SIO_000772 11221884 NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_provenance.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion evidence source_evidence_literature NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_provenance.
- NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_assertion description "[Serum-free conditioned medium from three prostate adenocarcinoma cell lines, LNCaP, PC3, and DU145, was added to cultures of fibroblasts established from prostatic tissue of patients with benign prostatic hyperplasia, and the medium was harvested at 24, 48, and 72 h. Immunoblotting with an antiversican core protein antibody revealed that prostatic fibroblast medium harvested at 72 h contained increased levels of versican after treatment with either LNCaP-, PC3- or DU145-conditioned medium (2.5-, 4.5-, and 5-fold, respectively) compared with control cultures.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309254.RAjtXnSFm2ma-AvwXnvRpbLtXEa5wofl2zbh37uzcg5UU130_provenance.